menu search

Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments

If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so.  Fresh from a US$31.25 million fundraise and...

February 23, 2022, 6:31 am

Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments

If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so.  Fresh from a US$31.25 million fundraise and...

February 23, 2022, 6:31 am

Sigyn therapeutics to present at the bullseye small cap virtual investor conference

SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:...

January 25, 2022, 8:00 am

Sigyn therapeutics to present at the bullseye small cap virtual investor conference

SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:...

January 25, 2022, 8:00 am

Sigyn therapeutics to present at the bullseye small cap virtual investor conference

SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:...

January 25, 2022, 8:00 am

Is progyny a good buy opportunity at the current share price?

Progyny, Inc (NASDAQ: PGNY) shares have weakened more than 20% since November 05, even though the compa...

December 27, 2021, 1:43 pm

Is progyny a good buy opportunity at the current share price?

Progyny, Inc (NASDAQ: PGNY) shares have weakened more than 20% since November 05, even though the compa...

December 27, 2021, 1:43 pm

Is progyny a good buy opportunity at the current share price?

Progyny, Inc (NASDAQ: PGNY) shares have weakened more than 20% since November 05, even though the compa...

December 27, 2021, 1:43 pm


Search within

Pages Search Results: